NCT00046501View on ClinicalTrials.gov

Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

February 28, 2005

Conditions
Diabetes Mellitus
Interventions
DRUG

Lantus (insulin glargine [rDNA origin] injection)

DRUG

Humulin N

DRUG

Humulin L

DRUG

Lispro

Trial Locations (1)

08807

Aventis, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY